Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 11, No 3 (2018) What is the role of antineoplastic drug safety in reimbursement decision making? Abstract  similar documents
A. S. Kolbin, A. A. Kurylev
"... . Aim: To evaluate the role of drug safety in making the decision on reimbursement. Materials ..."
 
Vol 9, No 1 (2016) MATHEMATICAL MODEL OF REIMBURSEMENT DECISION MAKING IN RUSSIA. RESULTS OF VIM LIST FOR 2016 Abstract  similar documents
A. S. Kolbin, A. V. Prasolov, E. A. Maksimkina, Yu. E. Balykina, Z. M. Golant, Yu. S. Polushin, A. A. Kurylev, I. A. Vilyum
"... in 2014 were used. In 2015 we included data on 141 drug dossiers. We analyzed the decision of the expert ..."
 
Vol 11, No 3 (2018) The concept of multi-criteria analysis of decision-making in the current system of health technology assessment in Russia Abstract  similar documents
V. V. Omelyanovsky, V. K. Fedyaeva, N. Z. Musina
"... the principles of health technologies assessment (HTA) and the reimbursement strategies in Russia have been put ..."
 
Vol 12, No 2 (2019) Health technology assessment and reimbursement of pharmaceuticals in Italy Abstract  similar documents
F. V. Gorkavenko, V. V. Omelyanovskiy, T. P. Bezdenezhnykh, G. R. Khachatryan
"... ) is the national health technology assessment (HTA) authority in charge of the reimbursement and formulary-listing ..."
 
Vol 7, No 4 (2014) APPLICATION OF MULTIPLE-CRITERIA ANALYSIS FOR OPTIMIZATION OF FINANCING OF RARE DISEASES Abstract  similar documents
V. V. Omelyanovskiy, V. K. Fedyaeva, O. Yu. Rebrova
"...  objectivity and transparency of decisions in the area of rare diseases. The main advantage of multiple ..."
 
Vol 12, No 4 (2019) The health technology assessment system in Australia Abstract  similar documents
V. V. Omelyanovskiy, E. S. Saybel, T. P. Bezdenezhnykh, G. R. Khachatryan
"... influence the committee decision. In addition to the full reimbursement of pharmaceuticals, the committee ..."
 
Vol 8, No 1 (2015) PAYMENT OF NEW EXPENSIVE TECHNOLOGIES IN HEALTH CARE ON THE BASIS OF RISKS -SHARING AGREEMENTS: POSSIBILITIES OF APPLICATION IN THE RUSSIAN FEDERATION Abstract  similar documents
L. S. Melnikova
"... are used in foreign countries at reimbursement of costs for public drug supply. The author estimates ..."
 
Vol 11, No 2 (2018) Regional adaptation of the federal model of reimbursement for medical assistance based on clinical statistical groups: hospitalization of patients in need of genetically enginered biological preparations Abstract  similar documents
M. V. Sura, T. N. Ignatova, N. S. Rudneva, Yu. N. Sukhanova, N. G. Ulyanova, A. S. Khudyaev, V. A. Shelyakin, D. V. Scherbakov
"... ) in 2018 provides for the reimbursement for hospital stay expenses by the compulsory medical insurance fund ..."
 
Vol 11, No 2 (2018) Introduction of medical products into healthcare practice and costs reimbursement: European experience Abstract  similar documents
V. V. Omelyanovsky, S. S. Otstavnov, N. Z. Musina, V. S. Dombrovskii
 
Vol 12, No 2 (2019) Organizational structure and funding of health technology assessment agencies around the world Abstract  similar documents
G. R. Khachatryan, V. V. Omelyanovskiy, L. S. Melnikova, S. S. Ratushnyak
"... : «organizational structure of HTA agency», «funding of HTA agency», «pharmaceutical», «reimbursement», «healthcare ..."
 
Vol 10, No 1 (2017) RESTRICTIVE LISTS OF DRUGS: REGULATIONS, FUNCTIONS, SOURCES OF FINANCE, AND GUIDELINES FOR CREATION Abstract  similar documents
M. V. Sura
 
Vol 10, No 3 (2017) Review of the current approaches to the assessment of the drug innovative potential worldwide Abstract  similar documents
N. Z. Musina, V. K. Fedyaeva, V. V. Omel’yanovskii, G. R. Khachatryan, K. V. Gerasimova, V. A. Lemeshko, K. P. Konchits
"... significance of a new medical product and make an educated decision on the reimbursement, cost and priority ..."
 
Vol 11, No 2 (2018) Pharmacoeconomic analysis of treatment with nilotinib as the second line therapy in patients with chronic myeloid leukemia Abstract  similar documents
N. A. Avxentyev, M. Yu. Frolov, A. S. Makarov
"... are registered in second-line, however only dasatinib is included in the government drug reimbursement program ..."
 
Vol 7, No 4 (2014) IS RUSSIA READY FOR THE INTRODUCTION OF THE NATIONAL REFERENCE PRICING SYSTEM? Abstract  similar documents
V. V. Omelyanovskiy
"... reimbursement) shows a substantial variety and presence of national peculiarities; however the majority ..."
 
Vol 10, No 3 (2017) Decision modelling for the evaluation of diabetes outcomes Abstract  similar documents
A. A. Mosikian, W. Zhao, T. L. Galankin, A. S. Kolbin
"... The process of decision modelling in diabetes mellitus (DM) is often complicated by comorbidity ..."
 
Vol 5, No 1 (2012) PHARMACOECONOMICS AS A NEW INSTRUMENT OF PHARMACEUTICAL MARKETING Abstract  similar documents
M. V. Protsenko, N. I. Koroleva
"... to convey to health care decision makers and how to bring this information full, correct, and easy ..."
 
Vol 11, No 4 (2018) International experience in determining the cost-effectiveness thresholds Abstract  similar documents
T. P. Bezdenezhnykh, N. Z. Musina, V. K. Fedyaeva, T. S. Tepcova, V. A. Lemeshko, V. V. Omelyanovsky
"... ), in Australia and new Zealand. The CeT is commonly used to rationalize decision-making in health cost ..."
 
Vol 7, No 4 (2014) MODELING IN CLINICO-ECONOMIC ANALYSIS OF MEDICAL ORGANIZATIONAL TECHNOLOGIES Abstract  similar documents
M. A. Shapovalova, A. R. Umerova, V. A. Bondarev, L. R. Koretskaya
"... decision tree and Markov model we used for calculating the anticipated costs when comparing two ..."
 
Vol 11, No 3 (2018) Determination of a willingness-to-pay threshold and decision-making in financing the healthcare technologies Abstract  similar documents
T. S. Teptsova, T. P. Bezdenezhnyh, V. K. Fedyaeva, N. Z Musina, G. R. Hachatryan, V. V. Tarasov
 
Vol 7, No 4 (2014) ROAD MAP FOR DEVELOPMENT OF PRICE REGULATION SYSTEM AND SYSTEM OF DRUG SUPPLY AT THE EXPENSE OF RUSSIAN FEDERATION HEALTHCARE SYSTEM FUNDS Abstract  similar documents
M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentieva
"... . A structured interview was conducted which involved 11 experts - key participants of the drug price regulation ..."
 
Vol 12, No 4 (2019) Clinical and economic analysis of drug costs in a general hospital in 2014-2018 Abstract  similar documents
A. T. Burbello, A. S. Fedorenko, E. L. Latariya, M. V. Pokladova, K. A. Zagorodnikova
"... with a simultaneous analysis of case histories. Results. The analysis of drug purchases in 2014-2018 and the obtained ..."
 
Vol 10, No 2 (2017) THE USE OF MULTI-CRITERIAL DECISION ANALYSIS (MCDA) FOR ESTIMATING THE THERAPEUTIC VALUE OF INNOVATIVE DRUGS Abstract  similar documents
V. K. Fedyaeva, V. V. Omelyanovskiy, N. Z. Musina, G. R. Khachatryan, O. I. Ivakhnenko
 
Vol 5, No 1 (2012) EСOLOGO-ECONOMIC PROBLEMS OF TECHNOGENIC INFLUENCE OF POLLUTION ON DISEASE OF THE POPULATION Abstract  similar documents
A. I. Borodin, E. M. Ovchinnikov
"... decision-making on maintenance of quality of environment ..."
 
Vol 9, No 1 (2016) PHARMACOECONOMIC EVALUATION OF RUFINAMIDE USE FOR THE LENNOX-GASTAUT SYNDROME TREATMENT Abstract  similar documents
N. K. Mazina, P. V. Mazin, Yu. V. Kislitsin, E. M. Markova
"... the chances of successful result (HR=3.1 [2.0; 4.9], p=0.000). Pharmacoeconomic modelling (a decision tree ..."
 
Vol 8, No 2 (2015) PRINCIPLES OF IMPORT SUBSTITUTION REGARDING DRUGS Abstract  similar documents
Alana Viktorovna Dzaneva, Vitalii Vladimirovich Omel'yanovskii, Saniyat Aleksandrovna Kagermazova
"... ограничительных перечней на различных уровнях системы здравоохранения. В статье рассматривается методология ..."
 
Vol 9, No 3 (2016) EARLY HEALTH TECHNOLOGIES ASSESSMENT — NEW APPROACH TO IMPROVING THE EFFICIENCY OF THE MEDICAL TECHNOLOGY DEVELOPMENT PROCESS Abstract  similar documents
N. Z. Musina, V. V. Omelyanovskiy, A. V. Krasheninnikova
"... включения технологии (лекарственного препарата) в ограничительные перечни, а также определить приемлемую для ..."
 
Vol 9, No 2 (2016) PHARMACOECONOMIC ANALYSIS OF VESOMNI (SOLIFENACIN AND CONTROLLED RELEASE TAMSULOSIN) TREATMENT OF STORAGE SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA Abstract  similar documents
N. A. Avxentyev, M. Yu. Frolov
"... tamsulosin and solifenacin therapy, including 35,400 patients eligible for government reimbursement. Using ..."
 
Vol 12, No 2 (2019) New framework for the development of clinical guidelines in Russia Abstract  similar documents
D. V. Blinov, E. S. Akarachkova, A. S. Orlova, E. V. Kryukov, D. I. Korabelnikov
"... guidelines”. In addition, we used the documents of regulatory bodies of the Russian Federation, expert ..."
 
Vol 9, No 2 (2016) EVALUATION OF RATIONALITY OF EXPENSES ON TREATMENT OF SEVERE COMMUNITY-ACQUIRES PNEUMONIA IN MULTI-PROFILE HOSPITAL Abstract  similar documents
I. V. Demko, N. V. Gordeeva, E. N. Bochanova, N. I. Golovina, A. Yu. Kraposhina, I. A. Soloveva, E. A. Sobko, T. V. Gaygolnik, S. V. Chubarova
"... in 2004, 2011 and 2014. The frequency analysis was applied to studying the structure of the carried-out ..."
 
Vol 8, No 2 (2015) REASONS FOR DIFFICULTY OF THE PHARMACOECONOMIC ANALYSIS FOR ORPHAN DRUGS. WAYS FOR SOLUTIONS Abstract  similar documents
Andrey Vladislavovich Pavlysh, Aleksei Sergeevich Kolbin, Roman Andreevich Gapeshin, Stanislav Mikhailovich Malyshev
"... definition of a rare disease and no universal approach to orphan drugs legislation. As a result, decision ..."
 
Vol 8, No 4 (2015) APPROACHES TO THE CONCEPTS OF PRODUCTIVITY, EFFICIENCY AND EFFECTIVENESS IN THE FIELD OF SCIENTIFIC RESEARCH AND DEVELOPMENT Abstract  similar documents
O. F. Seliverstova
"... decision-making needs to be redressed. Recommendations on fixing these concepts in normative legal ..."
 
Vol 11, No 4 (2018) Patient registers and account registries of compulsory medical insurance: integration and replaceability Abstract  similar documents
I. A. Zheleznyakova, G. I. Pirova, E. A. Proxorovich
"... for making organizational decisions on the healthcare system. The aim of this study is to review ..."
 
Vol 12, No 4 (2019) Developing clinical guidelines and assessing the quality of medical care using the RAND/UCLA method Abstract  similar documents
O. O. Buzuverova, V. K. Fedyaeva, O. A. Sukhorukikh
"... to consider both the relevant scientific data and the opinion of leading experts for deciding on the specifics ..."
 
Vol 12, No 3 (2019) Clinical and economic analysis as an instrument for harmonizing import substitution in the preferential segment of medicinal support Abstract  similar documents
E. V. Eliseeva , E. S. Maneeva , R. K. Goncharova , A. V. Kropotov
"... in 2014; in 2014-2015 it dropped significantly to 53.8% and 54.1%, respectively. In Region 2, the similar ..."
 
Vol 6, No 4 (2013) Using indirect comparisons in pharmacoeconomic examination Abstract  similar documents
Yu. E. Balykina, A. S. Kolbin
"... is the data of clinical studies. The experts are interested in not only the effect of a new medical technology ..."
 
Vol 12, No 1 (2019) Individual cost accounting in the management of medical organizations Abstract  similar documents
I. A. Zheleznyakova, L. A. Kovaleva, T. A. Khelisupali
"... a close internal management of financial activity. This function helps decision-makers: control the use ..."
 
Vol 5, No 2 (2012) METHODOLOGY OF COST-UTILITY ANALYSIS IN PHARMACOECONOMICSTUDIES Abstract  similar documents
R. I. Yagudina, I. V. Sorokovikov
"... and appropriate treatment alternatives. All stages of cost-utility analysis and decision making algorithm ..."
 
Vol 9, No 2 (2016) MANAGEMENT ASPECT OF THE PROBLEM OF NARCOTIC DRUGS USE Abstract  similar documents
S. Yu. Soboleva, A. V. Sobolev, I. A. Kaminskaya
"... imbalance in the system of record and control of narcotic drugs and suggests using in its decision real ..."
 
Vol 7, No 3 (2014) ASSESSMENT OF NECESSARY FINANCIAL EXPENSES ON THE DRUG SUPPLY OF THE PATIENTS WITH ORPHAN DISEASES IN THE RUSSIAN FEDERATION Abstract  similar documents
M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentyeva
"... of the official request of the Expert Board on Healthcare of the Council of the Federation Committee on Social ..."
 
Vol 10, No 1 (2017) THE USE OF QALY AS AN INTEGRAL MEASURE OF EFFECTIVENESS IN THE EVALUATION OF MEDICAL TECHNOLOGIES Abstract  similar documents
N. Z. Musina, V. K. Fedyaeva
"... better decision-making on financing the medical treatment within a limited budget. With this algorithm ..."
 
Vol 10, No 3 (2017) Initiation and intensification of insulin therapy in patients with type 2 diabetes mellitus: a budget impact analysis Abstract  similar documents
E. V. Biryukova, V. I. Ignat’eva
"... created a “decision tree” model that allowed us to calculate the costs of 48-week insulin therapy in 1000 ..."
 
Vol 8, No 3 (2015) LEGAL REGULATION OF STATE MANAGEMENT OF MEDICAL SCIENCE Abstract  similar documents
L. S. Melnikova, O. Yu. Rebrova, V. V. Omelyanovskiy
"... 23 августа 1996 г. N 127-ФЗ «О науке и государственно-технической политике» (ред. от 22.12.2014 ..."
 
Vol 8, No 3 (2015) RESEARCH EXCELLENCE INDEX AS INSTRUMENT OF PERFORMANCE-ORIENTED BUDGETING Abstract  similar documents
O. V. Bogacheva, V. E. Grigorov
"... (combining both qualitative methods and experts’ opinions) are successfully used in distribution of research ..."
 
Vol 10, No 3 (2017) Comparative pharmaco-economic analysis of using enzalutamide, abiraterone and cabazitaxel in post-docetaxel castration-resistant prostate cancer patients Abstract  similar documents
N. K. Mazina, P. V. Mazin
"... . The pharmacoeconomic advantages of enzalutamide over the two other agents are supported by the «decision tree» model ..."
 
Vol 11, No 1 (2018) CYP2D6 genotyping in the daily routine of a psychiatric hospital – pharmacoeconomic evaluation Abstract  similar documents
A. A. Kurylev, B. V. Andreev, A. S. Kolbin, O. V. Limankin
"... decision-making model was created. The model calculates direct medical costs for the patient care ..."
 
Vol 8, No 4 (2015) PHARMACOECONOMIC EVALUATION OF INFLUENZA AND PNEUMOCOCCAL VACCINATION IN EMPLOYEES OF THE JOINT STOCK COMPANY "RUSSIAN RAILWAYS" (JSCO "RZD") ON INVESTMENT FOR THE EMPLOYER Abstract  similar documents
D. A. Zhukov
"... » (JSCo «RZD») followed for 7 months during the 2013-2014 influenza season to collect data on influenza ..."
 
Vol 9, No 1 (2016) SYSTEMATIC REVIEW OF PENTAGLOBIN EFFICACY IN PREVENTING MORTALITY IN NEWBORNS AND OLDER CHILDREN WITH BACTERIAL INFECTIONS AND SEPSIS Abstract  similar documents
V. K. Fedyaeva, O. Yu. Rebrova
"... separately. Methods. We searched publications in PubMed and the Cochrane Library in December 2014 ..."
 
Vol 9, No 2 (2016) PHARMACO-ECONOMIC ANALYSIS OF COST IN TERMS OF MAINTENANCE OF PREFERENTIAL MEDICINES PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON THE TERRITORY OF KRASNOYARSK REGION Abstract  similar documents
T. V. Gaygolnik, I. V. Demko, E. N. Bochanova, A. Yu. Kraposhina, N. V. Gordeeva, I. A. Soloveva
"...  preparations to patients with the code J44 on the territory of Krasnoyarsk region for 2014 was used ..."
 
Vol 10, No 2 (2017) CLINICAL AND ECONOMIC EVALUATION OF CHRONIC DISEASE TREATMENT: A DISCREPANCY BETWEEN THE TRADITIONAL PHARMACOECONOMIC AND SOCIO-ECONOMIC ANALYSES Abstract  similar documents
O. V. Zhukova, S. V. Kononova
"... of asthma exacerbations in children hospitalized in 2014-2015 were used (total 608 cases). Results ..."
 
Vol 12, No 1 (2019) Evaluation of the clinical efficacy of anti-asthma pharmacotherapy in children using the software package based on the Fishburn method Abstract  similar documents
O. V. Zhukova, I. V. Nikiforova
"... of pharmacotherapy in 608 pediatric patients with BA treated in the hospital of Nizhny Novgorod in 2014-2015. We ..."
 
1 - 50 of 60 Items 1 2 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)